Englander Institute for Precision Medicine

Publications

Found 832 results
Author Title Type [ Year(Asc)]
2024
Meleshko D, Yang R, Maharjan S, Danko DC, Korobeynikov A, Hajirasouliha I.  2024.  Blackbird: structural variant detection using synthetic and low-coverage long-reads.. bioRxiv.
De Martino M, Rathmell JC, Galluzzi L, Vanpouille-Box C.  2024.  Cancer cell metabolism and antitumour immunity.. Nat Rev Immunol.
Chen X, Augello MA, Liu D, Lin K, Hakansson A, Sjöström M, Khani F, Deonarine LD, Liu Y, Travascio-Green J et al..  2024.  Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostate.. Nat Commun. 15(1):10675.
Kepp O, Galluzzi L, Petroni G.  2024.  Cellular senescence and aging at the crossroad between immunity and cancer.. Methods Cell Biol. 181:xvii-xxiv.
Gao VR, Yang R, Das A, Luo R, Luo H, McNally DR, Karagiannidis I, Rivas MA, Wang Z-M, Barisic D et al..  2024.  ChromaFold predicts the 3D contact map from single-cell chromatin accessibility.. Nat Commun. 15(1):9432.
Vitale I, Galassi C, Galluzzi L.  2024.  Chromosomal instability drives immunosuppression and metastatic dissemination.. Cell Res. 34(1):7-8.
Kasi PM, Lee JK, Pasquina LW, Decker B, Borre PVanden, Pavlick DC, Allen JM, Parachoniak C, Quintanilha JCF, Graf RP et al..  2024.  Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types.. Clin Cancer Res. 30(4):836-848.
Meleshko D, Prjbelski AD, Raiko M, Tomescu AI, Tilgner H, Hajirasouliha I.  2024.  cloudrnaSPAdes: isoform assembly using bulk barcoded RNA sequencing data.. Bioinformatics. 40(2)
Li S, Wong A, Sun H, Bhatia V, Javier G, Jana S, Wu Q, Montgomery RB, Wright JL, Lam H-M et al..  2024.  A combinatorial genetic strategy for exploring complex genotype-phenotype associations in cancer.. Nat Genet. 56(3):371-376.
Batra R, Krumsiek J, Wang X, Allen M, Blach C, Kastenmüller G, Arnold M, Ertekin-Taner N, Kaddurah-Daouk R.  2024.  Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer's disease and progressive supranuclear palsy.. Alzheimers Dement.
Al-Ishaq RKhalid, Ferrara CR, Stephan N, Krumsiek J, Suhre K, Montrose DC.  2024.  A Comprehensive Metabolomic and Microbial Analysis Following Dietary Amino Acid Reduction in Mice.. Metabolites. 14(12)
Izadmehr S, Fernandez-Hernandez H, Wiredja D, Kirschenbaum A, Lee-Poturalski C, Tavassoli P, Yao S, Schlatzer D, Hoon D, Difeo A et al..  2024.  Cooperativity of c-MYC with Krüppel-Like Factor 6 Splice Variant 1 induces phenotypic plasticity and promotes prostate cancer progression and metastasis.. bioRxiv.
Siew K, Nestler KA, Nelson C, D'Ambrosio V, Zhong C, Li Z, Grillo A, Wan ER, Patel V, Overbey E et al..  2024.  Cosmic kidney disease: an integrated pan-omic, physiological and morphological study into spaceflight-induced renal dysfunction.. Nat Commun. 15(1):4923.
Lira MCecilia, Galluzzi L, Vanpouille-Box C.  2024.  COX2-dependent suppression of anticancer immunity.. Trends Cancer.
Noch EK, Palma L, Yim I, Bullen N, Barnett D, Walsh A, Bhinder B, Benedetti E, Krumsiek J, Gurvitch J et al..  2024.  Cysteine induces mitochondrial reductive stress in glioblastoma through hydrogen peroxide production.. Proc Natl Acad Sci U S A. 121(8):e2317343121.
Beltrán-Visiedo M, Del Valle ASerrano-, Jiménez-Aldúan N, Soler-Agesta R, Naval J, Galluzzi L, Marzo I.  2024.  Cytofluorometric assessment of calreticulin exposure on CD38+ plasma cells from the human bone marrow.. Methods Cell Biol. 189:189-206.
Uemura M, Kikukawa H, Hashimoto Y, Uemura H, Mizokami A, Kato M, Matsushima H, Kosaka T, Nakamura M, Fukasawa S et al..  2024.  Darolutamide in Japanese patients with metastatic hormone-sensitive prostate cancer: Phase 3 ARASENS subgroup analysis.. Cancer Med. 13(21):e70029.
Markowitz GJ, Ban Y, Tavarez DA, Yoffe L, Podaza E, He Y, Martin MT, Crowley MJP, Sandoval TA, Gao D et al..  2024.  Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve immunotherapy.. Nat Immunol. 25(10):1884-1899.
Ohara K, Assaad MAl, McNulty SN, Alnajar H, Sboner A, Wilkes DC, He F, Xiang JZhaoying, Mathew S, Elemento O et al..  2024.  Detection of rare and novel gene fusions in patients with diffuse glioma: An institutional retrospective study.. J Neuropathol Exp Neurol.
Klomp JE, J Diehl N, Klomp JA, A Edwards C, Yang R, Morales AJ, Taylor KE, Drizyte-Miller K, Bryant KL, Schaefer A et al..  2024.  Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer.. Science. 384(6700):eadk0850.
Greenberg JA, Shah Y, Ivanov NA, Marshall T, Kulm S, Williams J, Tran C, Scognamiglio T, Heymann JJ, Lee-Saxton YJoo et al..  2024.  Developing a predictive model for metastatic potential in pancreatic neuroendocrine tumor.. J Clin Endocrinol Metab.
Forbes ANeil, Xu D, Cohen S, Pancholi P, Khurana E.  2024.  Discovery of therapeutic targets in cancer using chromatin accessibility and transcriptomic data.. Cell Syst.
McIntyre CA, Grimont A, Park J, Meng Y, Sisso WJ, Seier K, Jang GHo, Walch H, Aveson VG, Falvo DJ et al..  2024.  Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer.. Cancer Cell. 42(9):1614-1629.e5.
Risnik D, Colado A, Podaza E.  2024.  Editorial: Myeloid cell reprogramming: molecular pathways involved in disease development.. Front Immunol. 15:1414482.
Shore ND, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford D, Tombal B, Nordquist L, Cookson M, Verholen F et al..  2024.  Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS Trial.. Oncologist. 29(3):235-243.